Alonzo TA - Search Results

1

High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.

Walter RB, Alonzo TA, Gerbing RB, Ho PA, Smith FO, Raimondi SC, Hirsch BA, Gamis AS, Franklin JL, Hurwitz CA, Loken MR, Meshinchi S. Walter RB, et al. Among authors: alonzo ta. J Clin Oncol. 2010 Jun 10;28(17):2831-8. doi: 10.1200/JCO.2009.27.5693. Epub 2010 Apr 26. J Clin Oncol. 2010. PMID: 20421533 Free PMC article.

2

Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group.

Woods WG, Barnard DR, Alonzo TA, Buckley JD, Kobrinsky N, Arthur DC, Sanders J, Neudorf S, Gold S, Lange BJ. Woods WG, et al. Among authors: alonzo ta. J Clin Oncol. 2002 Jan 15;20(2):434-40. doi: 10.1200/JCO.2002.20.2.434. J Clin Oncol. 2002. PMID: 11786571 Clinical Trial.

3

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

Sievers EL, Lange BJ, Alonzo TA, Gerbing RB, Bernstein ID, Smith FO, Arceci RJ, Woods WG, Loken MR. Sievers EL, et al. Among authors: alonzo ta. Blood. 2003 May 1;101(9):3398-406. doi: 10.1182/blood-2002-10-3064. Epub 2002 Dec 27. Blood. 2003. PMID: 12506020 Free article.

4

Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia.

Meshinchi S, Stirewalt DL, Alonzo TA, Zhang Q, Sweetser DA, Woods WG, Bernstein ID, Arceci RJ, Radich JP. Meshinchi S, et al. Among authors: alonzo ta. Blood. 2003 Aug 15;102(4):1474-9. doi: 10.1182/blood-2003-01-0137. Epub 2003 Apr 17. Blood. 2003. PMID: 12702504 Free article.

5

Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.

Wells RJ, Adams MT, Alonzo TA, Arceci RJ, Buckley J, Buxton AB, Dusenbery K, Gamis A, Masterson M, Vik T, Warkentin P, Whitlock JA; Children's Cancer Group Study 2951. Wells RJ, et al. Among authors: alonzo ta. J Clin Oncol. 2003 Aug 1;21(15):2940-7. doi: 10.1200/JCO.2003.06.128. J Clin Oncol. 2003. PMID: 12885813 Clinical Trial.

6

Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.

Gamis AS, Woods WG, Alonzo TA, Buxton A, Lange B, Barnard DR, Gold S, Smith FO; Children's Cancer Group Study 2891. Gamis AS, et al. Among authors: alonzo ta. J Clin Oncol. 2003 Sep 15;21(18):3415-22. doi: 10.1200/JCO.2003.08.060. Epub 2003 Jul 28. J Clin Oncol. 2003. PMID: 12885836 Clinical Trial.

7

Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941.

Lange BJ, Dinndorf P, Smith FO, Arndt C, Barnard D, Feig S, Feusner J, Seibel N, Weiman M, Aplenc R, Gerbing R, Alonzo TA. Lange BJ, et al. Among authors: alonzo ta. J Clin Oncol. 2004 Jan 1;22(1):150-6. doi: 10.1200/JCO.2004.04.016. J Clin Oncol. 2004. PMID: 14701777 Clinical Trial.

8

Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition.

Brown P, Meshinchi S, Levis M, Alonzo TA, Gerbing R, Lange B, Arceci R, Small D. Brown P, et al. Among authors: alonzo ta. Blood. 2004 Sep 15;104(6):1841-9. doi: 10.1182/blood-2004-03-1034. Epub 2004 May 27. Blood. 2004. PMID: 15166029 Free article.

9

Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia.

Tse W, Meshinchi S, Alonzo TA, Stirewalt DL, Gerbing RB, Woods WG, Appelbaum FR, Radich JP. Tse W, et al. Among authors: alonzo ta. Blood. 2004 Nov 15;104(10):3058-63. doi: 10.1182/blood-2003-12-4347. Epub 2004 Jun 24. Blood. 2004. PMID: 15217837 Free article. Clinical Trial.

10

PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group.

Loh ML, Reynolds MG, Vattikuti S, Gerbing RB, Alonzo TA, Carlson E, Cheng JW, Lee CM, Lange BJ, Meshinchi S; Children's Cancer Group. Loh ML, et al. Among authors: alonzo ta. Leukemia. 2004 Nov;18(11):1831-4. doi: 10.1038/sj.leu.2403492. Leukemia. 2004. PMID: 15385933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page